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Abstract
Intestinal infections and diarrhoeal diseases of humans are under-reported yet each account
worldwide for more deaths than those from Tuberculosis. For external gut pathogens to do this
they have to penetrate, survive and prosper in an established and defended ecosystem comprising
the human gut with a massive immune system, a structured tight mucosal lining and a lumen densely
occupied by a huge community of diverse bacteria adapted to their environment and optimised in
a balanced and mutually beneficial relationship with its host.
Commentary
Human and animal intestines are cellular ecosystems of
immense complexity comprising mucosal and luminal
compartments. Methodological advances particularly in
high throughput DNA sequencing with its computational
tools and metagenomics have allowed our explorations to
probe further into the nature of the relevant microbial
communities, most of whose members have never been
cultured [1,2]. A study of the fecal microbiota of 60 mam-
malian species found the majority of sequences belonging
to the Firmicutes and Bacteroides with additional Proteo-
bacteria, Actinobacteria, Verrucomicrobia, Fusobacteria
and others in diminishing proportions. There was greater
similarity within host species than between species. The
similarity held up in the same animal species whether in
captivity or in the wild. There was close clustering by diet
within herbivores, omnivores or carnivores with herbiv-
ores having the most and carnivores the fewest phyla and
humans corresponded to omnivores [3].
The gut of newborn humans becomes progressively pop-
ulated from the environment and converges towards the
adult type over the first year [4]. In adults the intestinal
microbiota mostly in the luminal compartment number
in their trillions (1014). They form a remarkably stable
community of up to about 40,000 species of bacteria with
differences influenced by the genetic makeup of the host,
diet, geographical location, age and the presence of
inflammatory disease. The microbiota of the mucosal
compartment, comprising the intestinal epithelium and
surface adherent mucus layer, is necessarily smaller and
significantly different from those of the lumen and faeces;
it tends to be host specific, is uniform along the colon, sur-
face fucosylated in conformity with the environment of
the intestinal epithelium and less influenced by disease
[5-7].
These dynamic microbial communities are controlled and
ordered in co-operation and competition by quorum
sensing and social recognition signalling molecules which
also communicate with the host. In turn host messengers
such as noradrenalin released in host stress responses as
well as many other hormones, can influence the gut
microbiome with effects for example on microbial
growth, metabolism and expression of virulence factors
[8]. Members of the gut microbiome make a substantial
contribution to nutrient digestion and absorption includ-
ing vitamins and micronutrients and modulate human
metabolic phenotypes [9]. The intestinal microbiome by
influencing the expression of host genes and interacting
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with epithelial cells particularly through Toll-like recep-
tors ensures the proper post-natal maturation of the gut,
stimulation of innate immune defences, the development
of Peyer's patches and IgA production, angiogenesis, the
education of the adaptive immune system and develop-
ment of immunological tolerance [10,11].
Given the huge diversity of the microbial inhabitants of
our gut the groups of external pathogens known to be able
to destabilise it and cause common enteric diseases seems
relatively limited. There are viruses such as Rotavirus caus-
ing severe dehydrating gastroenteritis in infants and chil-
dren, enteric Adenoviruses, Noroviruses responsible for
foodborne outbreaks and traveller's diarrhoea and Astro-
viruses. Bacteria such as Salmonella, Shigella, Helicobacter,
Vibrio, Campylobacter, Yersinia, Clostridia and Listeria. Fungi
such as Candida  and  Histoplasma. Protozoa like Crypt-
osporidium, Giardia, Entamoeba and Cycolspora. Helminths
like Whipworm, Hookworm, Pinworm and Roundworm
including  Ascaris  and  Strongyloidiasis. The majority of
these pathogens are zoonotic. Bacterial invaders have to
survive the dense microbial environment of the gut and
have developed multiple mechanisms for the invasion of
the host [12]. The human population of Earth and the
numbers of food animals needed to sustain us are both
increasing. With regional and international travel together
with increasing transport and trade of animals and foods,
as well as spreading microbial antibiotic resistance we can
expect the global burden of disease caused by gut patho-
gens to grow.
Common enteric diseases caused by well established
external pathogens are not the only challenges we face.
The enteric microbiome is a fertile environment for hori-
zontal gene transfer [13]. Bacteria adapt and their
genomes change [14,15]. Recent evidence shows that the
common enteric bacterium Escherichia coli may display
predictive behaviour on transition from the conditions of
the outside world to those inside the mammalian intes-
tine [16]. In other words they may be able to learn. These
processes may be the means by which some commensal
inhabitants of the gut have turned against their hosts and
have evolved into pathogens. Examples include toxin pro-
ducing vancomycin resistant Enterococcus faecalis and E.
coli which can now be enteropathogenic, enterohaemor-
rhagic, enterotoxigenic, enteroaggregative, enteroadher-
ent and enteroinvasive.
Inflammatory bowel diseases particularly ulcerative colitis
(UC) and Crohn's disease (CD) are 'new' diseases which
emerged perceptibly in Western Europe and North Amer-
ica in the middle of the twentieth century. They have
increased in incidence and prevalence to become major
healthcare and economic problems throughout Europe
and North America as well as in other countries such as
New Zealand and Australia. CD is generally increasing in
incidence and prevalence and is now rising in former low
incidence countries such as India, Korea, Japan and
China. Genetic mutations conferring an increased suscep-
tibility are clearly indentified in a proportion of people
with these diseases, as they are in other chronic infections
such as leprosy. The genetic data provide valuable insights
into disease mechanisms.
The development of CD is known to involve one or more
environmental factors. Exposure to Mycobacterium avium
subspecies paratuberculosis (MAP) is a strong candidate.
MAP is a multi-host intracellular pathogen which can
cause systemic infection and chronic inflammation of the
intestine in many species including primates. MAP infec-
tion can also persist for years without progressing to clin-
ical disease. A recent survey by the US Department of
Agriculture found that 68.1% of dairy operations in the
USA are infected with MAP. These gut pathogens are trans-
mitted to human populations in milk supplies and from
sources of environmental contamination. They are diffi-
cult to detect in humans but when appropriate methods
are used most people with CD are found to be infected.
MAP causes a primary immune dysregulation and enteric
neuropathy. The integrity of the mucosa is compromised.
Segments of gross granulomatous inflammation result
mostly from a perturbed neuroimmune response to the
secondary penetration into the gut wall of microbiota and
food residues from the gut lumen. The long term persist-
ence of enteric MAP infection without gross inflammatory
disease but with microscopic immune activation and neu-
ropathy would perturb particularly the mucosal compart-
ment of the gut. This would have created a distorted
microenvironment conducive to the emergence of
mutated E. coli which together with other gut microbiota
act as important secondary co-pathogens in CD.
There is much to be done. A major effort in the field of
modern vaccines is of great importance. The new journal
'Gut Pathogens' as an additional medium for reporting
and debating the science and medicine in this field in the
interests of the lives and health of all humanity is most
welcome.
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